Cryoport Systems

Just Released: Cryoport $CYRX announced Q2 2024 Financial Results. Check out our earnings recap below and full report here: https://lnkd.in/gddF-6wH ▪️ Commercial Cell & Gene Therapy revenue increased 𝟱𝟭% year-over-year and 𝟮𝟬% sequentially ▪️ A record total of 𝟲𝟴𝟰 global clinical trials supported as of June 30, 2024 ▪️ Cost reduction initiatives anticipated to result in approximately $𝟮𝟮 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 of annualized cost savings and drive Cryoport towards its goal of profitable growth, as well as a return to positive Adjusted EBITDA in 2025

Trust Cryoport Systems for superior performance and reliability in transporting your valuable #AdvancedTherapies with #CryoportElite™ Ultra Cold -60 to -80°C shipper. Our dry ice shipping systems provide maximum protection for your high-value commodities throughout transit. $CYRX Learn More: https://cyrx.co/3JePD7m

The Cryoport team engaged with so many wonderful industry experts at #ISCTEurope24 this week. We enjoyed discussing topics such as cryopreservation and the management of a cell and gene therapy cold chain. $CYRX Connect with one of our experts to continue the conversation:  Dominic Clarke Alexandre Michaux Agnieszka Kocus-Cooijmans, PharmD, MBA Thibaut Dassesse Yu Zhang, PhD

Give your gene therapy the best chance of success with Cryoport Systems. Our end-to-end supply chain platform – which includes biostorage, drug labeling, robust dry ice shipping systems and shipping risk assessments – supports your research from development to delivery within a single vendor relationship for streamlined, optimized solutions that proactively mitigate risk every step of the way. https://cyrx.co/3Ve8uVW #GeneTherapy #SupplyChain $CYRX

Cryoport Systems is committed to supporting the fight against cancer. Our robust platform of #SupplyChain solutions supports the secure transport of therapies to patients' bedsides on a global scale. 🌎 🩸 ❤️ Let's work together to #EndCancer. 💪 #BloodCancerAwarenessMonth #ChildhoodCancerAwarenessMonth #OvarianCancerAwarenessMonth

Cryoport Systems is in Gothenburg, Sweden for the #ISCT Europe 2024 Regional Meeting this week. Be sure to join the session titled "Cell and Gene Therapy Cold Chain Management: From Logistics to Product Design" with Dominic Clarke, Vice President - Technical Operations, Integricell. Visit our event page for more information: https://cyrx.co/ISCT-EU $CYRX

We are honored to be a Silver Sponsor for this year's NMDP Gala in Minneapolis. This event is dedicated to making a significant difference in the lives of transport patients and their families. $CYRX #NMDP

We stand at the forefront of traceability with our platform of #SupplyChain solutions. Our BioServices and biostorage, shipping systems, logistics, cryopreservation, & consulting services can be counted on to meet GMP and GDP standards, assuring #compliance throughout every step of your supply chain. #EnableTheOutcome $CYRX Learn More: https://cyrx.co/3WrAzv1

One week until Advanced Therapies EU! Find us at booth #40, where we will connect with participants to discuss Cryoport Systems' recent expansions and how we have continued to be the strategic partner of choice for temperature-controlled supply chain management of critical materials around the world. Find out more on our event page: https://cyrx.co/3WIXzFJ $CYRX

Don't gamble with the stability of your biomaterials. Temperature-controlled storage solutions from Cryoport Systems enable reliable, GMP-compliant storage at every stage of your cold chain journey. Learn More: https://cyrx.co/4bvgicW #Stability #Reliability #CryoportSystems $CYRX